SCHEMBL1704182

SCHEMBL1704182

O=C(O)N(Br)c1cccc(F)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
PARP1 P09874 1/20 0.41
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
KCNN4 O15554 2/20 0.39
LTB4R2 Q9NPC1 2/20 0.39
NPC1 O15118 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
PTGIR P43119 1/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CETP P11597 1/20 0.38
EPHX1 P07099 1/20 0.37
ALDH1A1 P00352 1/20 0.37
NR4A1 P22736 1/20 0.37
NR4A2 P43354 1/20 0.37
NR4A3 Q92570 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20560250 0.83 CES2 (0.42) CES2CES1PARP1HDAC1HDAC6
SCHEMBL2089025 0.77 CES2 (0.44) CES2CES1PARP1LTB4R2MEN1
SCHEMBL2131568 0.77 PARP1 (0.46) CES2CES1PARP1HDAC1HDAC6
SCHEMBL29460301 0.77 CES2 (0.44) CES2CES1PARP1LTB4R2MEN1
SCHEMBL2094984 0.77 NPSR1 (0.48) CES2CES1PARP1KCNN4NPC1
SCHEMBL1704086 0.77 RAB9A (0.49) PARP1NPC1RAB9AMEN1KMT2A
SCHEMBL1006640 0.77 HTR3E (0.43) PARP1NPC1RAB9AMEN1KMT2A
SCHEMBL3042400 0.77 NPSR1 (0.50) NPC1RAB9AMEN1KMT2AALDH1A1
SCHEMBL1703719 0.77 CES2 (0.49) CES2RAB9AMEN1KMT2ACETP
SCHEMBL20560293 0.76 CTSL (0.36) CES2CES1PARP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558069-A1 BENZONAPTHYRIDINE COMPOSITIONS AND USES THEREOF Novartis AG (CH) 2013-02-20 EP disclosed
EP-2512478-A1 HOMOGENEOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF Novartis AG (CH) 2012-10-24 EP disclosed
EP-2440245-A1 BENZONAPHTHYRIDINE-CONTAINING VACCINES Novartis AG (CH) 2012-04-18 EP disclosed
WO-2011130379-A1 BENZONAPTHYRIDINE COMPOSITIONS AND USES THEREOF NOVARTIS AG (CH) 2011-10-20 WO disclosed
WO-2011084549-A1 HOMOGENEOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF NOVARTIS AG (CH) 2011-07-14 WO disclosed
CN-102015651-A Compounds and compositions as TLR activity modulators IRM LLC 2011-04-13 CN disclosed
WO-2010144734-A1 BENZONAPHTHYRIDINE-CONTAINING VACCINES NOVARTIS AG (CH) 2010-12-16 WO disclosed